Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature
暂无分享,去创建一个
[1] Craig S. Wong,et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Friedrich,et al. Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. , 2012, Glycobiology.
[3] A. Friedrich,et al. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells , 2012, Biological chemistry.
[4] J. Gariépy,et al. Charged and Hydrophobic Surfaces on the A Chain of Shiga-Like Toxin 1 Recognize the C-Terminal Domain of Ribosomal Stalk Proteins , 2012, PloS one.
[5] P. Kubes,et al. Innate immunity in the vasculature: interactions with pathogenic bacteria. , 2012, Current opinion in microbiology.
[6] A. Linstedt,et al. Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis , 2012, Science.
[7] V. L. Tesh,et al. Activation of cell stress response pathways by Shiga toxins , 2012, Cellular microbiology.
[8] A. Torres,et al. Molecular Mechanisms That Mediate Colonization of Shiga Toxin-Producing Escherichia coli Strains , 2011, Infection and Immunity.
[9] I. Rodrı́guez-Crespo,et al. Protein palmitoylation and subcellular trafficking. , 2011, Biochimica et biophysica acta.
[10] J. Barbieri,et al. Unique ganglioside binding by botulinum neurotoxins C and D‐SA , 2011, The FEBS journal.
[11] Klaus Stark,et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. , 2011, The New England journal of medicine.
[12] H. Karch,et al. Recent outbreak of hemolytic uremic syndrome in Germany. , 2011, Kidney international.
[13] R. Würzner,et al. Inhibition of terminal complement activation in severe Shiga toxin-associated HUS – perfect example for a fast track from bench to bedside , 2011, EMBO molecular medicine.
[14] M. Mormann,et al. Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. , 2011, Biochimica et biophysica acta.
[15] Kai Simons,et al. Membrane organization and lipid rafts. , 2011, Cold Spring Harbor perspectives in biology.
[16] Y. Maeda,et al. Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.
[17] Alfred H. Merrill,et al. Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.
[18] S. Felix,et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial , 2011, The Lancet.
[19] Jing Huang,et al. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways. , 2011, Blood.
[20] A. Mellmann,et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.
[21] G. Węgrzyn,et al. Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria. , 2011, Future microbiology.
[22] M. Fessler,et al. Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.
[23] A. Mellmann,et al. Comparison of Multilocus Variable-Number Tandem-Repeat Analysis and Multilocus Sequence Typing for Differentiation of Hemolytic-Uremic Syndrome-Associated Escherichia coli (HUSEC) Collection Strains , 2011, Journal of Clinical Microbiology.
[24] M. Amelia,et al. Change in Conformation with Reduction of α-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1* , 2011, The Journal of Biological Chemistry.
[25] Ari Helenius,et al. Lipid-mediated endocytosis. , 2011, Cold Spring Harbor perspectives in biology.
[26] R. Langer,et al. Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit , 2011, Molecular Cancer Therapeutics.
[27] J. Rothberg,et al. Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology , 2011, PloS one.
[28] S. Bloom,et al. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. , 2011, Microbiology.
[29] D. Leyva-Illades,et al. Differential Response of the Human Renal Proximal Tubular Epithelial Cell Line HK-2 to Shiga Toxin Types 1 and 2 , 2011, Infection and Immunity.
[30] Jian Zhong,et al. From simple to complex: investigating the effects of lipid composition and phase on the membrane interactions of biomolecules using in situ atomic force microscopy. , 2011, Integrative biology : quantitative biosciences from nano to macro.
[31] G. Koudelka,et al. Shiga Toxin: Expression, Distribution, and Its Role in the Environment , 2011, Toxins.
[32] A. Edefonti,et al. Clinical Relevance of Shiga Toxin Concentrations in the Blood of Patients With Hemolytic Uremic Syndrome , 2011, The Pediatric infectious disease journal.
[33] S. Schüller. Shiga Toxin Interaction with Human Intestinal Epithelium , 2011, Toxins.
[34] G Krause,et al. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[35] D. Lingwood,et al. Cholesterol modulates glycolipid conformation and receptor activity. , 2011, Nature chemical biology.
[36] H. Karch,et al. Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPα , 2011, Environmental microbiology.
[37] A. Friedrich,et al. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S] , 2011, Journal of Lipid Research.
[38] C. Hovde,et al. Escherichia coli O157:H7: animal reservoir and sources of human infection. , 2011, Foodborne pathogens and disease.
[39] M. Miyazaki,et al. Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli. , 2011, Microbial pathogenesis.
[40] N. Engedal,et al. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells. , 2011, FEMS immunology and medical microbiology.
[41] N. Engedal,et al. Shiga toxin and its use in targeted cancer therapy and imaging , 2010, Microbial biotechnology.
[42] K. Sandvig,et al. Endocytosis and retrograde transport of Shiga toxin. , 2010, Toxicon : official journal of the International Society on Toxinology.
[43] Patrik Langehanenberg,et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.
[44] T. Obrig. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease , 2010, Toxins.
[45] A. Callan-Jones,et al. Lipid Cosorting Mediated by Shiga Toxin Induced Tubulation , 2010, Traffic.
[46] P. Tazzari,et al. Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. , 2010, The Biochemical journal.
[47] D. Motto,et al. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. , 2010, Blood.
[48] J. Paton,et al. Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli. , 2010, The Journal of infectious diseases.
[49] M. Schmidt,et al. LEEways: tales of EPEC, ATEC and EHEC , 2010, Cellular microbiology.
[50] Kai Simons,et al. Revitalizing membrane rafts: new tools and insights , 2010, Nature Reviews Molecular Cell Biology.
[51] H. Buhr,et al. Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. , 2010, Neoplasia.
[52] P. Quinn. A lipid matrix model of membrane raft structure. , 2010, Progress in lipid research.
[53] E. Kita,et al. Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin. , 2010, Microbial pathogenesis.
[54] Dora Brites,et al. Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.
[55] S. Johnson,et al. Pathophysiology of typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[56] A. Mellmann,et al. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation. , 2010, Seminars in thrombosis and hemostasis.
[57] F. Schaefer,et al. Treatment of typical (enteropathic) hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[58] R. Inagi,et al. Glomerular diseases: genetic causes and future therapeutics , 2010, Nature Reviews Nephrology.
[59] R. Würzner,et al. Complement in typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[60] C. Ackerley,et al. A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins* , 2010, The Journal of Biological Chemistry.
[61] A. Friedrich,et al. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[62] A. Friedrich,et al. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors[S] , 2010, Journal of Lipid Research.
[63] A. Caprioli,et al. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration , 2010, Journal of leukocyte biology.
[64] R. Coutinho-Silva,et al. Host‐cell lipid rafts: a safe door for micro‐organisms? , 2010, Biology of the cell.
[65] T. Beddoe,et al. Structure, biological functions and applications of the AB5 toxins. , 2010, Trends in biochemical sciences.
[66] Tore-Geir Iversen,et al. Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine , 2010, FEBS letters.
[67] Jaakko Patrakka,et al. Molecular make-up of the glomerular filtration barrier. , 2010, Biochemical and biophysical research communications.
[68] R. Yu,et al. Membrane glycolipids in stem cells , 2010, FEBS letters.
[69] B. Binnington,et al. Globotriaosyl ceramide receptor function – Where membrane structure and pathology intersect , 2010, FEBS letters.
[70] R. Kolesnick,et al. Ceramide‐rich platforms in transmembrane signaling , 2010, FEBS letters.
[71] A. Surolia,et al. Glycosphingolipids in microdomain formation and their spatial organization , 2010, FEBS letters.
[72] K. Iwabuchi,et al. Significance of glycosphingolipid fatty acid chain length on membrane microdomain‐mediated signal transduction , 2010, FEBS letters.
[73] S. Hakomori. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility , 2010, FEBS letters.
[74] Patrik Langehanenberg,et al. Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy. , 2010, Journal of biomedical optics.
[75] J. Müthing,et al. Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. , 2010, Mass spectrometry reviews.
[76] W. Sessa,et al. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. , 2010, Cardiovascular research.
[77] C. Schengrund. Lipid rafts: Keys to neurodegeneration , 2010, Brain Research Bulletin.
[78] M. Morigi,et al. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.
[79] C. G. Hansen,et al. Exploring the caves: cavins, caveolins and caveolae. , 2010, Trends in cell biology.
[80] S. Tzipori,et al. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. , 2010, The Journal of infectious diseases.
[81] V. L. Tesh. Induction of apoptosis by Shiga toxins. , 2010, Future microbiology.
[82] S. Iyer,et al. Glycan‐based high‐affinity ligands for toxins and pathogen receptors , 2010, Medicinal research reviews.
[83] J. Hunt. Shiga Toxin–Producing Escherichia coli (STEC) , 2010, Clinics in Laboratory Medicine.
[84] L. Johannes,et al. Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.
[85] M. Veit,et al. FLIM-FRET and FRAP reveal association of influenza virus haemagglutinin with membrane rafts. , 2010, The Biochemical journal.
[86] S. Bourdoulous,et al. Breaking the wall: targeting of the endothelium by pathogenic bacteria , 2010, Nature Reviews Microbiology.
[87] J. Paton,et al. Escherichia coli Subtilase Cytotoxin , 2010, Toxins.
[88] V. Gannon,et al. Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.
[89] K. Sandvig,et al. Interplay between Toxin Transport and Flotillin Localization , 2010, PloS one.
[90] T. Okuda,et al. Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-α stimulation , 2010, Glycoconjugate Journal.
[91] Kai Simons,et al. Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.
[92] Richard J Thomas,et al. Receptor mimicry as novel therapeutic treatment for biothreat agents , 2010, Bioengineered bugs.
[93] T. Johnson,et al. Pathogenomics of the Virulence Plasmids of Escherichia coli , 2009, Microbiology and Molecular Biology Reviews.
[94] H. Schnittler,et al. Between microbial attack and defence: The endothelium as a vulnerable player in infectious diseases , 2009, Thrombosis and Haemostasis.
[95] Shefali Sabharanjak,et al. Endocytosis of glycosylphosphatidylinositol-anchored proteins , 2009, Journal of Biomedical Science.
[96] John Cowden,et al. Escherichia coli O157 , 2009, BMJ : British Medical Journal.
[97] A. Brunger,et al. Receptor and substrate interactions of clostridial neurotoxins. , 2009, Toxicon : official journal of the International Society on Toxinology.
[98] R. Schnaar,et al. Gangliosides in cell recognition and membrane protein regulation. , 2009, Current opinion in structural biology.
[99] C. Lingwood,et al. Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes , 2009, Journal of Lipid Research.
[100] A. Friedrich,et al. Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer , 2009, PloS one.
[101] K. Iwabuchi,et al. Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils , 2009, Glycoconjugate Journal.
[102] A. Varki,et al. A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome. , 2009, Kidney international.
[103] M. Mehran,et al. Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers , 2009, Antimicrobial Agents and Chemotherapy.
[104] A. Shevchenko,et al. Glycosphingolipid Requirements for Endosome‐to‐Golgi Transport of Shiga Toxin , 2009, Traffic.
[105] C. G. Hansen,et al. Molecular mechanisms of clathrin-independent endocytosis , 2009, Journal of Cell Science.
[106] T. Binz,et al. Cell entry strategy of clostridial neurotoxins , 2009, Journal of neurochemistry.
[107] C. Lingwood,et al. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. , 2009, Kidney international.
[108] H. Karch,et al. Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome1 , 2009, The Journal of Immunology.
[109] A. Mellmann,et al. Intrahost genome alterations in enterohemorrhagic Escherichia coli. , 2009, Gastroenterology.
[110] A. Mellmann,et al. Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.
[111] H. Karch,et al. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin , 2009, Molecular microbiology.
[112] S. Hell,et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.
[113] S. Sonnino,et al. Sphingolipids and membrane environments for caveolin , 2009, FEBS letters.
[114] W. Min,et al. Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.
[115] M. Bitzan. Treatment options for HUS secondary to Escherichia coli O157:H7. , 2009, Kidney international. Supplement.
[116] A. Friedrich,et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury , 2009, Thrombosis and Haemostasis.
[117] F. Braet,et al. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier , 2009, American journal of physiology. Renal physiology.
[118] David F. Smith,et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin , 2008, Nature.
[119] A. Bonev,et al. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. , 2008, The Journal of infectious diseases.
[120] A. Caprioli,et al. Interactions between Shiga toxins and human polymorphonuclear leukocytes , 2008, Journal of leukocyte biology.
[121] L. P. Van den Heuvel,et al. Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[122] B. Binnington,et al. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide‐containing lipid assemblies , 2008, Journal of cellular physiology.
[123] L. Zimmerhackl,et al. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS) , 2008, Pediatric Nephrology.
[124] A. Mellmann,et al. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.
[125] P. Sens,et al. Biophysical approaches to protein-induced membrane deformations in trafficking. , 2008, Current opinion in cell biology.
[126] M. Noda,et al. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. , 2008, Microbial pathogenesis.
[127] X. Sastre,et al. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool , 2008, Molecular Cancer Therapeutics.
[128] G. Remuzzi,et al. Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin1 , 2008, The Journal of Immunology.
[129] C. Silberstein,et al. Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2 , 2008, Pediatric Nephrology.
[130] T. Yutsudo,et al. Shiga Toxin 2 Causes Apoptosis in Human Brain Microvascular Endothelial Cells via C/EBP Homologous Protein , 2008, Infection and Immunity.
[131] K. Iwabuchi,et al. Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. , 2008, Biochimica et biophysica acta.
[132] R. Cherla,et al. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells , 2008, Cellular microbiology.
[133] S. Hakomori,et al. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. , 2008, Biochimica et biophysica acta.
[134] S. Hakomori. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. , 2008, Biochimica et biophysica acta.
[135] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[136] B. Kemper,et al. Digital holographic microscopy for live cell applications and technical inspection. , 2008, Applied optics.
[137] K. Sandvig,et al. Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity , 2008, Histochemistry and Cell Biology.
[138] A. Friedrich,et al. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity , 2008, Glycoconjugate Journal.
[139] E. Boedeker,et al. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.
[140] T. Obrig,et al. p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and Tumor Necrosis Factor Alpha Induction of Shiga Toxin 2 Sensitivity in Human Umbilical Vein Endothelial Cells , 2007, Infection and Immunity.
[141] Katharina Gaus,et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.
[142] P. Marquet,et al. Digital holographic microscopy applied to life sciences , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[143] D. Lingwood,et al. Detergent resistance as a tool in membrane research , 2007, Nature Protocols.
[144] D. Vestweber. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium , 2007, Immunological reviews.
[145] N. Suttorp,et al. Extra- and intracellular innate immune recognition in endothelial cells , 2007, Thrombosis and Haemostasis.
[146] A. Mellmann,et al. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[147] A. Futerman,et al. The metabolism and function of sphingolipids and glycosphingolipids , 2007, Cellular and Molecular Life Sciences.
[148] B. Ballermann. Contribution of the Endothelium to the Glomerular Permselectivity Barrier in Health and Disease , 2007, Nephron Physiology.
[149] L. P. Van den Heuvel,et al. Interactions of Shiga-like toxin with human peripheral blood monocytes , 2007, Pediatric Nephrology.
[150] J. Hancock,et al. Lipid rafts and membrane traffic , 2007, FEBS letters.
[151] Ajit Varki,et al. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.
[152] B. Tesfamariam,et al. Endothelial injury in the initiation and progression of vascular disorders. , 2007, Vascular pharmacology.
[153] M. Bakovic,et al. Lipid rafts in health and disease , 2007, Biology of the cell.
[154] R. Parton,et al. The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.
[155] A. Friedrich,et al. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. , 2007, Microbes and infection.
[156] R. Titball,et al. The Rational Design of Bacterial Toxin Inhibitors , 2007 .
[157] Mark M. Rasenick,et al. Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.
[158] N. Wilke,et al. Biophysics of sphingolipids II. Glycosphingolipids: an assortment of multiple structural information transducers at the membrane surface. , 2006, Biochimica et biophysica acta.
[159] J. van Marle,et al. Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. , 2006, The Biochemical journal.
[160] L. Johannes,et al. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. , 2006, Kidney international.
[161] J. Paton,et al. Shiga toxin 'goes retro' in human primary kidney cells. , 2006, Kidney international.
[162] Deborah A. Brown,et al. Lipid rafts, detergent-resistant membranes, and raft targeting signals. , 2006, Physiology.
[163] L. Johannes,et al. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells , 2006, The FEBS journal.
[164] L. Monnens,et al. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells , 2006, Pediatric Nephrology.
[165] R. Henriksson,et al. Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines , 2006, Cancer biology & therapy.
[166] Y. Fujinaga. Transport of bacterial toxins into target cells: pathways followed by cholera toxin and botulinum progenitor toxin. , 2006, Journal of biochemistry.
[167] H. Tsai. The molecular biology of thrombotic microangiopathy. , 2006, Kidney international.
[168] M. James,et al. Binding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7. , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.
[169] Ryuzo Azuma,et al. Particle simulation approach for subcellular dynamics and interactions of biological molecules , 2006, First International Multi-Symposiums on Computer and Computational Sciences (IMSCCS'06).
[170] N. Kahya. Targeting membrane proteins to liquid-ordered phases: molecular self-organization explored by fluorescence correlation spectroscopy. , 2006, Chemistry and physics of lipids.
[171] Sandro Sonnino,et al. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. , 2006, Chemical reviews.
[172] Wei Lang,et al. Advancing glycomics: implementation strategies at the consortium for functional glycomics. , 2006, Glycobiology.
[173] A. Friedrich,et al. Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.
[174] L. V. D. Heuvel,et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. , 2006, Kidney international.
[175] R. Spooner,et al. Retrograde transport pathways utilised by viruses and protein toxins , 2006, Virology Journal.
[176] C. Mineo,et al. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. , 2006, Cardiovascular research.
[177] Nathan Sharon,et al. Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.
[178] A. Friedrich,et al. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. , 2006, Seminars in thrombosis and hemostasis.
[179] C. Silberstein,et al. Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. , 2006, Microbes and infection.
[180] R. Pagano,et al. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids (Review) , 2006, Molecular membrane biology.
[181] A. Friedrich,et al. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. , 2005, Rapid communications in mass spectrometry : RCM.
[182] W. Lencer,et al. Raft trafficking of AB5 subunit bacterial toxins. , 2005, Biochimica et biophysica acta.
[183] S. Abraham,et al. The role of lipid rafts in the pathogenesis of bacterial infections. , 2005, Biochimica et biophysica acta.
[184] L. Johannes,et al. Article Title: the Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect the Association of Shiga-like Toxin with Detergent- Resistant Membranes Is Modulated by Glucosylc , 2022 .
[185] Christian G Elowsky,et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[186] J. Moake,et al. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. , 2005, Blood.
[187] R. Polanowska-Grabowska,et al. Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function , 2005, Infection and Immunity.
[188] H. Karch,et al. Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.
[189] K. Sandvig,et al. Caveolae: Stable Membrane Domains with a Potential for Internalization , 2005, Traffic.
[190] F. Goñi,et al. Detergent-resistant membranes should not be identified with membrane rafts. , 2005, Trends in biochemical sciences.
[191] H. Karch,et al. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.
[192] Ken Hatano,et al. Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. , 2005, The Journal of infectious diseases.
[193] J. Garvin,et al. Recent advances in the regulation of nitric oxide in the kidney. , 2005, Hypertension.
[194] C. Tacket,et al. Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody cαStx2 Administered Intravenously to Healthy Adult Volunteers , 2005, Antimicrobial Agents and Chemotherapy.
[195] J. Ingelfinger,et al. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome * , 2005, Journal of thrombosis and haemostasis : JTH.
[196] Xiang-An Li,et al. Caveolae, lipid rafts, and vascular disease. , 2005, Trends in cardiovascular medicine.
[197] D. Haslam,et al. Shiga Toxin Is Transported from the Endoplasmic Reticulum following Interaction with the Luminal Chaperone HEDJ/ERdj3 , 2005, Infection and Immunity.
[198] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[199] L. Johannes,et al. Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications. , 2005, Toxicon : official journal of the International Society on Toxinology.
[200] E. Cuche,et al. Digital holographic microscopy: a noninvasive contrast imaging technique allowing quantitative visualization of living cells with subwavelength axial accuracy. , 2005, Optics letters.
[201] L. Barbieri,et al. Shiga toxin 1 and ricin inhibit the repair of H2O2-induced DNA single strand breaks in cultured mammalian cells. , 2005, DNA repair.
[202] P. Stricklett,et al. Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells. , 2005, The Journal of infectious diseases.
[203] H. Karch,et al. Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.
[204] Daniel Carl,et al. Parameter-optimized digital holographic microscope for high-resolution living-cell analysis. , 2004, Applied optics.
[205] A. Macconnachie,et al. Potential therapeutic agents for the prevention and treatment of haemolytic uraemic syndrome in shiga toxin producing Escherichia coli infection , 2004, Current opinion in infectious diseases.
[206] M. Lisanti,et al. Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.
[207] T. Kanda,et al. Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells , 2004, Journal of neuroscience research.
[208] L. Johannes,et al. Glycosphingolipids as toxin receptors. , 2004, Seminars in cell & developmental biology.
[209] N. Kiyokawa,et al. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells , 2004, Journal of Cell Science.
[210] J. Peter-Katalinic,et al. Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. , 2004, Analytical chemistry.
[211] D. Newburg,et al. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells. , 2004, Microbial pathogenesis.
[212] M. Brigotti,et al. Shiga toxin 1 acting on DNA in vitro is a heat-stable enzyme not requiring proteolytic activation. , 2004, Biochimie.
[213] E. Kita,et al. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. , 2004, The Journal of infectious diseases.
[214] M. Karmali. Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues. , 2004, The Journal of infectious diseases.
[215] E. Gratton,et al. Visualizing lipid structure and raft domains in living cells with two-photon microscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[216] S. Munro. Lipid Rafts Elusive or Illusive? , 2003, Cell.
[217] J. Peter-Katalinic,et al. Discrimination of neolacto-series gangliosides with alpha2-3- and alpha2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization low-energy collision-induced dissociation tandem quadrupole TOF MS. , 2003, Analytical chemistry.
[218] A. Cnaan,et al. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. , 2003, JAMA.
[219] David Botstein,et al. Endothelial cell diversity revealed by global expression profiling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[220] R. Parton,et al. Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms , 2003, Traffic.
[221] N. Koide,et al. Human microvascular endothelial cells resist Shiga toxins by IFN-γ treatment in vitro , 2003 .
[222] F. Gunzer,et al. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. , 2003, Blood.
[223] J. Harlan,et al. Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. , 2003, Microbial pathogenesis.
[224] David S. Park,et al. Caveolin, Caveolae, and Endothelial Cell Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[225] J. Fantini. How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains , 2003, Cellular and Molecular Life Sciences CMLS.
[226] K. Sandhoff,et al. Biosynthesis and degradation of mammalian glycosphingolipids. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[227] Ivan R. Nabi,et al. Caveolae/raft-dependent endocytosis , 2003, The Journal of cell biology.
[228] W. Aird. Endothelial cell heterogeneity , 2003, Critical care medicine.
[229] P. Marcato,et al. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. , 2003, The Journal of infectious diseases.
[230] A. Pavan,et al. Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes , 2003, Glycoconjugate Journal.
[231] C. Lingwood,et al. Induction by Sphingomyelinase of Shiga Toxin Receptor and Shiga Toxin 2 Sensitivity in Human Microvascular Endothelial Cells , 2003, Infection and Immunity.
[232] K. Sandvig,et al. Caveolae: anchored, multifunctional platforms in the lipid ocean. , 2003, Trends in cell biology.
[233] J. Harlan,et al. Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein Expression Sensitizes Endothelial Cells to Bacterial Lipopolysaccharide-induced Apoptosis* , 2002, The Journal of Biological Chemistry.
[234] K. Sandvig,et al. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin , 2002, FEBS letters.
[235] P. Stricklett,et al. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. , 2002, The Journal of infectious diseases.
[236] A. Kenworthy,et al. Peering inside lipid rafts and caveolae. , 2002, Trends in biochemical sciences.
[237] P. Stricklett,et al. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. , 2002, Journal of the American Society of Nephrology : JASN.
[238] G. Remuzzi,et al. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. , 2002, Kidney international.
[239] R. Proia,et al. Combinatorial Ganglioside Biosynthesis* , 2002, The Journal of Biological Chemistry.
[240] Ken Jacobson,et al. A Role for Lipid Shells in Targeting Proteins to Caveolae, Rafts, and Other Lipid Domains , 2002, Science.
[241] R. Stan. Structure and function of endothelial caveolae , 2002, Microscopy research and technique.
[242] Chisato Yamasaki,et al. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[243] L. Barbieri,et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells 1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[244] David G. E. Smith,et al. Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epithelium. , 2002, Journal of medical microbiology.
[245] A. Varki. Loss of N‐glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution , 2002, American journal of physical anthropology.
[246] S. Hakomori. INAUGURAL ARTICLE by a Recently Elected Academy Member:The glycosynapse , 2002 .
[247] H Nakajima,et al. Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.
[248] M. Donowitz,et al. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. , 2001, Journal of cell science.
[249] G. Remuzzi,et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. , 2001, Blood.
[250] G J Davies,et al. Protein--carbohydrate interactions: learning lessons from nature. , 2001, Trends in biotechnology.
[251] G. Remuzzi,et al. Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Rare manifestations of Russell’s viper (Daboia russelii) envenoming in Sri Lanka , 2021 .
[252] J. Salamero,et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.
[253] G. Molostvov,et al. Interaction of cytokines and growth factor in the regulation of verotoxin‐induced apoptosis in cultured human endothelial cells , 2001, British journal of haematology.
[254] V. V. van Hinsbergh,et al. Verocytotoxin-induced apoptosis of human microvascular endothelial cells. , 2001, Journal of the American Society of Nephrology : JASN.
[255] R. Morona,et al. Neutralization of Shiga Toxins Stx1, Stx2c, and Stx2e by Recombinant Bacteria Expressing Mimics of Globotriose and Globotetraose , 2001, Infection and Immunity.
[256] J. Pober,et al. Tumor Necrosis Factor Alpha Increases Human Cerebral Endothelial Cell Gb3 and Sensitivity to Shiga Toxin , 2001, Infection and Immunity.
[257] P. Accorsi,et al. Shiga toxin 1: damage to DNA in vitro. , 2001, Toxicon : official journal of the International Society on Toxinology.
[258] Tetsuya Mori,et al. Apoptosis of Renal Tubular Cells in Shiga-Toxin-Mediated Hemolytic Uremic Syndrome , 2001, Nephron.
[259] D. Brown,et al. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). , 2000, Biochimica et biophysica acta.
[260] Craig S. Wong,et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.
[261] V. V. van Hinsbergh,et al. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. , 2000, Blood.
[262] Y. Sanai,et al. Functional roles of glycosphingolipids in signal transduction via lipid rafts , 2000, Glycoconjugate Journal.
[263] J. Fantini,et al. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and perturbations of intestinal absorption and secretion , 2000, Glycoconjugate Journal.
[264] S. Hakomori. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain , 2000, Glycoconjugate Journal.
[265] R. Morona,et al. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans , 2000, Nature Medicine.
[266] R. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[267] L. Johannes,et al. Facing Inward from Compartment Shores: How Many Pathways were we Looking For? , 2000, Traffic.
[268] Tetsuya Mori,et al. Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains* , 1999, The Journal of Biological Chemistry.
[269] N. Koide,et al. Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. , 1999, The Journal of infectious diseases.
[270] C. Lingwood. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. , 1999, Biochimica et biophysica acta.
[271] J. Samuel,et al. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. , 1999, The Journal of infectious diseases.
[272] J. Peter-Katalinic,et al. Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. , 1999, Glycobiology.
[273] Y. Ihara,et al. Localization of verotoxin receptors in nervous system , 1999, Brain Research.
[274] D. Acheson,et al. Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis , 1999, Infection and Immunity.
[275] J. Rutka,et al. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells , 1998, Journal of Neuro-Oncology.
[276] Jcbn. Nomenclature of glycolipids , 1998 .
[277] M.Alan Chester,et al. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997. , 1998, European journal of biochemistry.
[278] N. Kiyokawa,et al. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. , 1998, Biochemical and biophysical research communications.
[279] H. Abboud,et al. Shiga toxin 1 elicits diverse biologic responses in mesangial cells. , 1998, Kidney international.
[280] L. Barbieri,et al. Shiga‐like toxin I is a polynucleotide:adenosine glycosidase , 1998, Molecular microbiology.
[281] R J Read,et al. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.
[282] V. V. van Hinsbergh,et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. , 1997, Journal of the American Society of Nephrology : JASN.
[283] T. Obrig,et al. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB , 1997, Infection and immunity.
[284] F. Gilles,et al. Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.
[285] V. V. van Hinsbergh,et al. Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells , 1997 .
[286] D. Acheson,et al. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. , 1996, The Journal of infectious diseases.
[287] C. Lingwood,et al. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes , 1996, Glycoconjugate Journal.
[288] V. L. Tesh,et al. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines , 1996, Infection and immunity.
[289] C. Lingwood. Role of verotoxin receptors in pathogenesis. , 1996, Trends in microbiology.
[290] J. Müthing. High-resolution thin-layer chromatography of gangliosides. , 1996, Journal of chromatography. A.
[291] G. Remuzzi,et al. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. , 1995, Blood.
[292] T. Obrig,et al. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. , 1995, The Journal of infectious diseases.
[293] C. Lingwood,et al. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin , 1995, Infection and immunity.
[294] K. Sandvig,et al. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. , 1995, Experimental cell research.
[295] T. Kooistra,et al. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. , 1995, Blood.
[296] H. Augustin,et al. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.
[297] R. Siegler. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. , 1994, The Journal of pediatrics.
[298] T. Obrig,et al. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. , 1994, Microvascular research.
[299] C. Lingwood,et al. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro , 1993, Infection and immunity.
[300] C. Lingwood,et al. Endothelial heterogeneity in Shiga toxin receptors and responses. , 1993, The Journal of biological chemistry.
[301] D. Marcus,et al. Variable subcellular localization of glycosphingolipids. , 1993, Glycobiology.
[302] V. V. van Hinsbergh,et al. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. , 1992, Blood.
[303] Kristian Prydz,et al. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.
[304] T. Obrig,et al. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro , 1992, Infection and immunity.
[305] C. Lingwood,et al. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. , 1992, Biochemistry.
[306] Deborah A. Brown,et al. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.
[307] S. Goerdt,et al. Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders , 1992, The clinical investigator.
[308] C. Lingwood,et al. cells to Shiga toxin . sensitivity of human umbilical vein endothelial syndrome : effect of sodium butyrate on Shiga toxin-associated hemolytic uremic , 1991 .
[309] C. Lingwood,et al. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. , 1991, The Journal of biological chemistry.
[310] J. Heath,et al. Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells. , 1991, Experimental cell research.
[311] D. Lewis,et al. Interferon-γ alters expression of endothelial cell-surface glycosphingolipids , 1990 .
[312] S. Ostroff,et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.
[313] C. Lingwood,et al. Globotetraosylceramide is recognized by the pig edema disease toxin. , 1989, The Journal of biological chemistry.
[314] B. Domon,et al. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates , 1988, Glycoconjugate Journal.
[315] L. Becker,et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.
[316] J. Brown,et al. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells , 1988, Infection and immunity.
[317] C. Lingwood,et al. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. , 1988, Biochemical and biophysical research communications.
[318] B. Domon,et al. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. , 1988, Biochemistry.
[319] M. P. Jackson,et al. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933 , 1987 .
[320] M. Jones,et al. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. , 1987, Archives of biochemistry and biophysics.
[321] C. Lingwood,et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.
[322] C. Edgell,et al. Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[323] L. Teel,et al. Pathogenesis of Shiga-toxin producing escherichia coli. , 2012, Current topics in microbiology and immunology.
[324] Silvia Scolari,et al. Applications of fluorescence lifetime spectroscopy and imaging to lipid domains in vivo. , 2012, Methods in enzymology.
[325] K. Sandvig,et al. Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.
[326] Y. Takata,et al. Encephalopathy, disseminated intravascular coagulation, and hemolytic–uremic syndrome after infection with enterohemorrhagic Escherichia coli O111 , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[327] J. Avorn. Eculizumab in Severe Shiga-Toxin-Associated HUS , 2011 .
[328] F. Obata,et al. Influence of Escherichia coli shiga toxin on the mammalian central nervous system. , 2010, Advances in applied microbiology.
[329] I. Nabi,et al. Lipid rafts, caveolae, and their endocytosis. , 2010, International review of cell and molecular biology.
[330] Y. Hannun,et al. An overview of sphingolipid metabolism: from synthesis to breakdown. , 2010, Advances in experimental medicine and biology.
[331] B. Binnington,et al. New aspects of the regulation of glycosphingolipid receptor function. , 2010, Chemistry and physics of lipids.
[332] D. Chi,et al. Endothelial cell biology: role in the inflammatory response. , 2010, Advances in clinical chemistry.
[333] J. Slotte,et al. How the molecular features of glycosphingolipids affect domain formation in fluid membranes. , 2009, Biochimica et biophysica acta.
[334] Patrik Langehanenberg,et al. Automated three-dimensional tracking of living cells by digital holographic microscopy. , 2009, Journal of biomedical optics.
[335] N. Loberto,et al. Glycosphingolipid behaviour in complex membranes. , 2009, Biochimica et biophysica acta.
[336] W. Aird. Endothelium in health and disease. , 2008, Pharmacological reports : PR.
[337] J. Thiem,et al. Glycoscience : chemistry and chemical biology , 2008 .
[338] S. Sonnino,et al. Gangliosides as components of lipid membrane domains. , 2007, Glycobiology.
[339] S. Sahni. Endothelial cell infection and hemostasis. , 2007, Thrombosis research.
[340] W. Lencer,et al. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. , 2007, FEMS microbiology letters.
[341] S. Levery. Glycosphingolipid structural analysis and glycosphingolipidomics. , 2005, Methods in enzymology.
[342] K. Jacobson,et al. Detecting microdomains in intact cell membranes. , 2005, Annual review of physical chemistry.
[343] W. Lencer. Retrograde transport of cholera toxin into the ER of host cells. , 2004, International journal of medical microbiology : IJMM.
[344] C. Lingwood,et al. Methods for the identification of host receptors for Shiga toxin. , 2003, Methods in molecular medicine.
[345] R. Benz,et al. Detection and characterization of EHEC-hemolysin. , 2003, Methods in molecular medicine.
[346] D. Kohan,et al. Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1. , 2003, The Journal of infectious diseases.
[347] Akihiro Kusumi,et al. Relationship of lipid rafts to transient confinement zones detected by single particle tracking. , 2002, Biophysical journal.
[348] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[349] J. Rutka,et al. The treatment of malignant meningioma with verotoxin. , 2002, Neoplasia.
[350] S. Hakomori. Inaugural Article : The glycosynapse , 2002 .
[351] E. Heinz,et al. Chemical Biology and Biomedicine: Glycolipids and Glycosphingolipids , 2001 .
[352] R. Kannagi. Monoclonal anti-glycosphingolipid antibodies. , 2000, Methods in enzymology.
[353] J. Müthing,et al. Analyses of glycosphingolipids by high-performance liquid chromatography. , 2000, Methods in enzymology.
[354] C. Lingwood,et al. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. , 1999, Oncology research.
[355] J. Müthing. TLC in structure and recognition studies of glycosphingolipids. , 1998, Methods in molecular biology.
[356] R. G. Anderson. The caveolae membrane system. , 1998, Annual review of biochemistry.
[357] C. Lingwood. Verotoxin-binding in human renal sections. , 1994, Nephron.
[358] M. P. Jackson,et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.
[359] A. Leung,et al. Causes of death in hemolytic uremic syndrome. , 1991, Child nephrology and urology.
[360] K. Karlsson. Animal glycosphingolipids as membrane attachment sites for bacteria. , 1989, Annual review of biochemistry.
[361] C. Sweeley,et al. Glycosphingolipids: structure, biological source, and properties. , 1989, Methods in enzymology.
[362] T. Yutsudo,et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.
[363] Joshua Jortner,et al. Nomenclature of retinoids: recommendations 1981. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). , 1983, Archives of biochemistry and biophysics.